copeia
Copeia is a German digital health company developing software for medical cannabis therapy, including reimbursement, dosing, and real-world evidence tools that serve physicians, patients, pharmacies, and health insurers.
- Company typePrivate
- Founded2020
- HeadquartersBergisch Gladbach, Germany
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What copeia does
Copeia GmbH is a German digital health company founded in 2020 and headquartered in Bergisch Gladbach, with additional offices in Cologne and Berlin. The company develops software tools for medical cannabis therapy workflows in Germany, serving physicians, patients, pharmacies, pharmaceutical companies, and statutory health insurers (GKV). Its core products are GKV-Check:CAM and GKV-Arztfragebogen:CAM, which automate insurance reimbursement applications and physician questionnaires under the German cannabis annex of the Medicines Directive (AM-RL); Copeia Dosis EQ, a dosing and titration planning tool; PEP, a real-world evidence platform aggregating physician case studies; and a cannabis product database accessible via QR codes in the VCA pharmacy network.
The underlying technology combines rule-based clinical and regulatory workflows with AI/NLP components used to process clinical trial data, patient surveys, and research outputs related to cannabinoids and psilocybin. The company collaborates with Boston Children's Hospital, Fraunhofer IAIS, and Ben-Gurion University on research, and integrates with DocCheck for physician and pharmacist authentication. Peer-reviewed publications co-authored with these partners validate the technical approach.
The business model is freemium for end users (physicians and patients), with planned B2B monetization from pharmaceutical companies, pharmacy chains, and health insurers. Distribution leverages the Verband der Cannabis versorgenden Apotheken (VCA) network of 50+ specialized pharmacies. The company has not disclosed funding rounds, revenue, or headcount beyond a stated 1-10 employee range, indicating an early-stage operating profile with research-driven credibility but limited commercial scale.
copeia firmographics
Firmographics- Name
- copeia
- Legal name
- Copeia GmbH
- Website
- https://copeia.info
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Copeia is a German digital health company developing software for medical cannabis therapy, including reimbursement, dosing, and real-world evidence tools that serve physicians, patients, pharmacies, and health insurers.
- Ownership category
- akta.pro rank
copeia industry classification
Industry- Product category
- Digital Health / Medical Cannabis Software
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where copeia is headquartered
LocationHeadquarters
- HQ city
- Bergisch Gladbach
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
copeia business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software / Digital Health Tools (B2B): Copeia provides digital health solutions to healthcare industry stakeholders — doctors, pharmacies, pharma companies, and health insurers — to optimize cannabis-based therapy. The company develops AI-based products and workflow solutions. Revenue appears to derive from B2B licensing/subscription arrangements with healthcare industry players rather than direct patient fees. Free tools for patients and physicians serve as acquisition/engagement mechanisms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free access for patients and physicians |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
copeia product offering
Product offeringCore offering
Copeia develops digital healthcare software for medical cannabis treatment and clinical workflows in Germany. Its product suite supports physicians with insurance reimbursement eligibility checks, structured application documentation, individual titration/dosing planning, and a physician-only real-world case documentation platform, while providing patients and pharmacies a transparent cannabis product database with batch-level QR code access. The platform combines AI/NLP-driven analytics with a growing proprietary real-world evidence repository, and the company serves healthcare industry stakeholders including pharmacies, pharma companies, and statutory health insurers through B2B arrangements.
Product overview
Copeia develops a suite of digital health solutions to support medical cannabis therapy, comprising five integrated tools: (1) GKV-Check:CAM and GKV-Arztfragebogen:CAM for streamlined insurance reimbursement assessment and application documentation; (2) Copeia Dosis EQ for individual titration planning and prescription template creation; (3) Physicians Experience Platform (PEP) as a structured Real-World database of physician case studies; and (4) CAM Database providing transparent product information and batch analysis access via pharmacy QR code partnerships. The platform supports both patients and healthcare industry stakeholders (physicians, pharmacies, pharma, insurers).
Differentiator
Problem solved
Functional benefit
Products and services
- GKV-Check:CAM A rapid, indication-specific evaluation tool that assesses prescription eligibility for medical cannabis under Germany's statutory health insurance (GKV), incorporating the legal framework and economic considerations. It is free for both physicians and patients.
- GKV-Arztfragebogen:CAM Structured questionnaire that guides healthcare professionals through all required documentation for insurance coverage applications per the German Pharmaceutical Directive (AM-RL), reducing formal errors and insurer queries. Access is restricted to medical professionals via DocCheck login.
- Copeia Dosis EQ Application enabling intuitive creation of individual titration plans and prescription templates for cannabis extracts and Dronabinol, with clear parameter visualization for complex dose calculations during initial prescription or therapy adjustments. Access via DocCheck login for medical professionals.
- Physicians Experience Platform (PEP) Structured real-world database and platform enabling physicians to document anonymized case studies of medical cannabis therapies, capturing indications, symptoms, medications, dosages, side effects, and quality of life outcomes via an interactive 9-section form. Supports case study search and comparison. Access via DocCheck login for medical professionals.
- CAM Database (Cannabis-Produkt Datenbank) Product database providing transparent overview of available cannabis medications with access to laboratory batch analyses via QR codes. In partnership with pharmacies, patients can scan QR codes to obtain detailed product-specific information including batch analysis certificates.
Quantifiable outcome
- 84% of surveyed patients reported significant improvement in quality of life under medical cannabis therapy
- +4 more outcomes
Companies that use copeia
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
copeia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature7 records
copeia partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Verband der Cannabis versorgenden Apotheken (VCA)coreVCA is the German Association of Cannabis-Supplying Pharmacies. Copeia partnered with VCA to distribute survey materials through a network of 50+ member pharmacies, enabling patient recruitment for research surveys. The partnership also facilitated distribution of QR code-based product information materials to patients through pharmacies.
- Cannabis Pharmacies (partners via QR code system)coreCopeia partners with German cannabis pharmacies to offer a QR code system on cannabis products. Patients scan the QR code to access batch-specific analysis certificates and detailed product information. This pharmacy partnership enables the product database and patient-facing transparency tool.
- Boston Children's Hospital (Information Services Department)coreLong-term strategic research partnership. Copeia co-authors research with staff from Boston Children's Hospital's Information Services Department. Multiple joint research publications on pharmacokinetics, sex differences in cannabinoid therapy, patient-reported outcomes, and AI/NLP methodologies. Assaf Landschaft holds positions at both organizations.
- Fraunhofer IAIS (Intelligent Analysis and Information Systems)coreResearch partnership with Fraunhofer IAIS for AI-driven medical cannabis research. Copeia's research on leveraging patient data repositories for medical cannabinoid research was presented at MCC 2024 and indexed in the Fraunhofer Publica repository. Assaf Landschaft holds a position at Fraunhofer IAIS.
- Patient Organizations (patient advocacy groups)minorCopeia collaborates with German patient organizations to distribute survey materials and reach patients for research surveys. Patient organizations helped recruit participants for the nationwide 2022 survey, which reached 1,582 participants.
- Ben-Gurion University of the NegevminorCopeia co-authored a systematic review of THC pharmacokinetics with researchers from Ben-Gurion University of the Negev (Department of Clinical Biochemistry and Pharmacology). David Stepensky co-authored the research.
- DocCheckcoreDocCheck is a German physician credentialing and authentication platform. Copeia uses DocCheck to gate access to professional tools (GKV-Arztfragebogen:CAM, Dosis EQ, PEP), ensuring that sensitive healthcare tools are accessible only to verified medical professionals.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
copeia competitors and assessment
Company assessmentDirect peers
- Algea Care: German telemedicine platform focused on medical cannabis prescriptions and patient management. Direct peer because it operates in the same German medical cannabis ecosystem, serving physicians and patients with digital workflows for cannabis therapy initiation and follow-up.
- Sanity Group: Berlin-based medical cannabis company spanning cultivation, distribution, and digital health tooling for patients and physicians. Direct peer because it is Germany-domiciled and combines cannabis supply with physician/patient-facing digital services in the same regulated reimbursement environment.
- Cannify: Cannabis product recommendation and education platform (originally Denmark/US) using patient profiling to match cannabis profiles to conditions. Direct peer because it shares Copeia's evidence-driven, structured-data approach to cannabis therapy decision support, even if delivery is via web rather than physician workflow.
Regional players
- Kanna Health (formerly KannaMed): German medical cannabis provider combining pharmacy distribution with patient digital services. Regional peer because it shares the German cannabis pharmacy ecosystem with Copeia and overlaps on patient education and access, though less focused on physician workflow tooling.
Broad incumbents
- Leafly Holdings: Largest global cannabis information platform with strain, product, and dispensary data plus patient/provider content. Broad incumbent peer because it shares the 'cannabis knowledge + discovery' layer of the patient journey that Copeia addresses through CAM Database and PEP.
- Weedmaps / WM Technology: US-listed cannabis marketplace connecting consumers, retailers, and brands with software and data layers. Broad incumbent peer because it operates at the intersection of dispensary software, product transparency, and patient-facing information — adjacent to Copeia's pharmacy-linked product database.
- IQVIA: Global leader in clinical research, real-world evidence, and healthcare data analytics serving pharma and life sciences. Broad incumbent peer because Copeia's PEP-based RWE ambitions and AI clinical-trial pipeline overlap with IQVIA's eCOA/CTMS/RWE franchise, even though IQVIA operates across all of healthcare.
- Flatiron Health: Oncology-focused real-world evidence and EHR-linked data platform acquired by Roche. Broad incumbent peer because its core play — aggregating structured clinician-documented cases into a research-grade dataset — is the same model Copeia is building for cannabis at a smaller scale.
- Doctolib: Dominant European digital health platform for appointment booking, teleconsultation, and physician workflow software across Germany, France, and Italy. Broad incumbent peer because Doctolib sits upstream of cannabis prescribing workflows and could plausibly bundle cannabis-specific decision support if the category scales.
Emerging players
- Caresyntax: Berlin-based AI-powered surgical and clinical data platform that aggregates structured perioperative data for outcomes research. Emerging player peer because it shares Copeia's playbook of using structured clinical data capture + AI/NLP to build evidence-rich datasets from frontline clinicians, though in surgery rather than cannabis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
copeia social profiles
Digital presencecopeia financial estimates
Financial estimateRevenue estimate
Valuation estimate
copeia leadership team
Management profileNumber of profiles
Profiles2 records
copeia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
copeia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about copeia
What does copeia do?
Copeia develops digital healthcare software for medical cannabis treatment and clinical workflows in Germany. Its product suite supports physicians with insurance reimbursement eligibility checks, structured application documentation, individual titration/dosing planning, and a physician-only real-world case documentation platform, while providing patients and pharmacies a transparent cannabis product database with batch-level QR code access. The platform combines AI/NLP-driven analytics with a growing proprietary real-world evidence repository, and the company serves healthcare industry stakeholders including pharmacies, pharma companies, and statutory health insurers through B2B arrangements.
Is copeia a public or private company?
copeia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was copeia founded?
copeia was founded in 2020. It employs 1 to 10 people.
Where is copeia based?
copeia is headquartered in Bergisch Gladbach, Germany, in the Europe region.
How does copeia make money?
One revenue line is on record: software / Digital Health Tools (B2B).
Who are copeia's main competitors?
Direct peers on record are Algea Care, Sanity Group and Cannify. Kanna Health (formerly KannaMed) is listed as a regional player. Broad incumbents are Leafly Holdings, Weedmaps / WM Technology, IQVIA, Flatiron Health and Doctolib. Caresyntax is listed as an emerging player.
Does copeia have an API?
No public API is recorded for copeia.
What industry is copeia in?
copeia's product category is Digital Health / Medical Cannabis Software. Its primary akta.pro industry code is HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 5132 and its SIC code is 7372.